Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2019 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Participate at Upcoming March Investor Conferences

ALACHUA, Fla., March 04, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
February 26, 2019 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Reports 2018 Fourth Quarter and Full Year 2018 Financial Results

Fourth Quarter Revenue of $23.4 million, representing 38% growth over prior yearFull Year 2018 Revenue of $83.9 million, representing 39% growth over prior year ALACHUA, Fla., Feb. 26, 2019 (GLOBE...
February 19, 2019 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Participate at Upcoming February Investor Conferences

ALACHUA, Fla., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
February 14, 2019 07:00 ET | Source: AxoGen, Inc.

Axogen, Inc. to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26, 2019

ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
January 24, 2019 07:00 ET | Source: AxoGen, Inc.

AxoGen to Participate at AAHS ASPN ASRM 2019 Annual Meetings

ALACHUA, Fla., Jan. 24, 2019 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
January 22, 2019 07:00 ET | Source: AxoGen, Inc.

AxoGen Appoints Eric Sandberg as Chief Commercial Officer

ALACHUA, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
January 15, 2019 08:00 ET | Source: AxoGen, Inc.

AxoGen Announces RECON® Study Update

ALACHUA, Fla., Jan. 15, 2019 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...
January 07, 2019 09:00 ET | Source: AxoGen, Inc.

AxoGen, Inc. Pre-Announces Financial and Operational Results

Q4 Revenue of at least $23.4 million, a 38% YoY increase FY 2018 Revenue of at least $83.9 million, a 39% YoY increase Company reaffirms 2019 financial guidance and provides business update ...
January 07, 2019 09:00 ET | Source: AxoGen, Inc.

AxoGen Appoints Christopher Crisman as Vice President, U.S. Sales

ALACHUA, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to...
December 06, 2018 07:00 ET | Source: AxoGen, Inc.

AxoGen Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float

ALACHUA, Fla., Dec. 06, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral...